FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

443713000: Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet (clinical drug)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    3502272013 Saxagliptin 5 mg oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
    3682917016 Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    59644101000001111 Saxagliptin 5mg tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Is a Product manufactured as oral dose form false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Is a Product containing saxagliptin false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has active ingredient Saxagliptin false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has active ingredient Saxagliptin false Inferred relationship Existential restriction modifier 1
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has basis of strength substance Saxagliptin false Inferred relationship Existential restriction modifier 1
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has presentation strength numerator value 5 false Inferred relationship Existential restriction modifier 1
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has presentation strength numerator unit milligram false Inferred relationship Existential restriction modifier 1
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet false Inferred relationship Existential restriction modifier 1
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has precise active ingredient Saxagliptin false Inferred relationship Existential restriction modifier 1
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Is a Product containing saxagliptin in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Is a Product containing only saxagliptin in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has active ingredient Saxagliptin false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has manufactured dose form Oral dose form false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Is a Virtual medicinal product false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has specific active ingredient Saxagliptin hydrochloride false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Saxagliptin false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has dispensed dose form Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has basis of strength substance Saxagliptin false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Has specific active ingredient Saxagliptin hydrochloride false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Onglyza 5mg tablets (Ethigen Ltd) Is a False Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Onglyza 5mg tablets (Pharmaram Ltd) Is a False Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Onglyza 5mg tablets (CST Pharma Ltd) Is a False Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Onglyza 5mg tablets (DE Pharmaceuticals) Is a False Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Saxagliptin 5mg tablets 28 tablet Has VMP False Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Is a False Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Onglyza 5mg tablets (Sigma Pharmaceuticals Plc) Is a False Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) Is a False Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Onglyza 5mg tablets (Waymade Healthcare Plc) Is a False Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start